A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease

作者：Reddy P Hemachandra^*

来源：Journal of Alzheimer's Disease, 2017, 57(4): 969-974.

DOI：10.3233/JAD-170256

• Amyloid-beta
• cognitive decline
• mitochondrial dysfunction
• synaptic pathology

The purpose of this mini-forum, "Neurotransmitters and Alzheimer's Disease", is to critically assess the current status of neurotransmitters in Alzheimer's disease. Neurotransmitters are essential neurochemicals that maintain synaptic and cognitive functions in mammals, including humans, by sending signals across pre-to post-synaptic neurons. Authorities in the fields of synapses and neurotransmitters of Alzheimer's disease summarize the current status of basic biology of synapses and neurotransmitters, and also update the current status of clinical trials of neurotransmitters in Alzheimer's disease. This article discusses the prevalence, economic impact, and stages of Alzheimer's dementia in humans.

• 出版日期2017